Lab data show Valneva vaccine effective against Omicron
Valneva announced yesterday that results from a lab study showed three doses of its inactivated COVID-19 vaccine candidate, VLA2001, neutralized the Omicron variant.
Archives for January 20, 2022
New year, new ADC deal: Abzena teams up with BiVictriX, Iksuda taps LegoChem again, Genmab secures access to Dutch tech
The past few weeks have witnessed a plethora of antibody-drug conjugate (ADC) related deals.
Vaccine manufacturing campus opens in South Africa
A new vaccine manufacturing plant has been opened in Cape Town by South Africa president Cyril Ramaphosa this week.
UK sets out on ‘once-in-generation’ opportunity to update clinical trial legislation
The UK Medicines and Healthcare products Regulatory Agency (MHRA) has launched a public consultation to improve and strengthen UK clinical trials legislation.